ADVANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the sphere of biopharmaceuticals, supplying promising improvements throughout different health-related and industrial applications. With its structural similarity to Obviously derived human serum albumin, OsrHSA presents a safer, much more trustworthy substitute for